Загрузка...
Drug synergy of combinatory treatment with remdesivir and the repurposed drugs fluoxetine and itraconazole effectively impairs SARS‐CoV‐2 infection in vitro
BACKGROUND AND PURPOSE: The SARS‐COV‐2 pandemic and the global spread of coronavirus disease 2019 (COVID‐19) urgently call for efficient and safe antiviral treatment strategies. A straightforward approach to speed up drug development at lower costs is drug repurposing. Here, we investigated the ther...
Сохранить в:
| Опубликовано в: : | Br J Pharmacol |
|---|---|
| Главные авторы: | , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
John Wiley and Sons Inc.
2021
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8251190/ https://ncbi.nlm.nih.gov/pubmed/33825201 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bph.15418 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|